SAN DIEGO, Sept. 10, 2007 (PRIME NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today announced that Yuichi Iwaki, M.D., PhD., Chief Executive Officer of MediciNova, will present a company overview at the 2007 UBS Global Life Sciences Conference on Wednesday, September 26, 2007 at 2:00 p.m. Eastern time. The conference is being held at the Grand Hyatt Hotel in New York City.
